Literature DB >> 29770006

Primary care pearls to help eliminate tuberculosis in Canada.

K R Amaratunga1,2, G G Alvarez3,4.   

Abstract

Although Canada has a low incidence of tuberculosis (TB), certain populations, including the foreign-born and Canadian-born Indigenous peoples, continue to be disproportionately represented among reported cases. The overall incidence rates of active TB in Canada have not significantly changed in the past decade and work still needs to be done to reach TB elimination goals set by the World Health Organization (WHO). In trying to achieve TB elimination in Canada, primary care clinicians, with the support of public health professionals and TB experts, can help by focusing on 1) targeted screening and treatment of latent TB infection (LTBI) and 2) timely diagnosis and referral of active TB disease. The following article focuses on some key primary care considerations to keep in mind in day-to-day patient care. To help conduct targeted screening and treatment for LTBI, several key populations, including immigrants from high TB burden countries, Indigenous peoples and several other at-risk groups, are outlined. Reactivation of LTBI plays a significant role in TB burden and is likely an area of major potential impact in achieving TB elimination. Advancement in LTBI treatment, including short course therapy, is also described. In addition, to help make a timely diagnosis of active TB, several key risk factors, including several co-morbidities which increase the risk of developing TB disease, can be considered. Being front-line in patient care, keeping in mind some of these key pearls may aid primary care providers to have potential impact on eliminating TB in Canada.

Entities:  

Year:  2016        PMID: 29770006      PMCID: PMC5864284          DOI: 10.14745/ccdr.v42i03a03

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  6 in total

1.  Domestic impact of tuberculosis screening among new immigrants to Ontario, Canada.

Authors:  Kamran Khan; M Mustafa Hirji; Jennifer Miniota; Wei Hu; Jun Wang; Michael Gardam; Sameer Rawal; Edward Ellis; Angie Chan; Maria I Creatore; Elizabeth Rea
Journal:  CMAJ       Date:  2015-09-28       Impact factor: 8.262

2.  Physician experience, public health and the management of tuberculosis.

Authors:  Richard Long
Journal:  CMAJ       Date:  2006-09-26       Impact factor: 8.262

3.  Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.

Authors:  M Elsa Villarino; Nigel A Scott; Stephen E Weis; Marc Weiner; Marcus B Conde; Brenda Jones; Sharon Nachman; Ricardo Oliveira; Ruth N Moro; Nong Shang; Stefan V Goldberg; Timothy R Sterling
Journal:  JAMA Pediatr       Date:  2015-03       Impact factor: 16.193

Review 4.  Making a timely diagnosis of pulmonary tuberculosis.

Authors:  Richard Long
Journal:  Can Respir J       Date:  2015-10-15       Impact factor: 2.409

5.  Three months of rifapentine and isoniazid for latent tuberculosis infection.

Authors:  Timothy R Sterling; M Elsa Villarino; Andrey S Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E Weis; Marc Weiner; Diane Wing; Marcus B Conde; Lorna Bozeman; C Robert Horsburgh; Richard E Chaisson
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

6.  Tuberculosis among foreign-born persons in the United States.

Authors:  Kevin P Cain; Stephen R Benoit; Carla A Winston; William R Mac Kenzie
Journal:  JAMA       Date:  2008-07-23       Impact factor: 56.272

  6 in total
  2 in total

1.  Addressing challenges in tuberculosis adherence via performance-based payments for integrated case management: protocol for a cluster randomized controlled trial in Georgia.

Authors:  Ivdity Chikovani; Karin Diaconu; Predrag Duric; Lela Sulaberidze; Maia Uchaneishvili; Nuredin Ibrahim Mohammed; Akaki Zoidze; Sophie Witter
Journal:  Trials       Date:  2019-08-28       Impact factor: 2.279

2.  Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries.

Authors:  Lena Faust; Anne McCarthy; Yoko Schreiber
Journal:  BMC Public Health       Date:  2018-08-06       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.